Search for Clinical Trial Results

Dermatitis, Exfoliative - 11 Studies Found
Status | Study |
Terminated |
Study Name: A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris Condition: Pityriasis Rubra Pilaris Date: 2008-12-29 Interventions: Drug: Alefacept 15mg intramuscular injection weekly for 12 weeks |
Completed |
Study Name: Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma Condition:
Interventions: Other: Detection of KIR receptor by RT PCR Detection on biopsy cutaneous (3mm) and on blood sample of 30 |
Completed |
Study Name: A Phase 3 Clinical Study of KHK 4827 Condition:
|
Completed |
Study Name: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis Condition:
|
Completed |
Study Name: An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis Condition: Psoriasis Date: 2013-01-27 Interventions: Drug: KHK4827 140 mg (dosage may be increased to 210 mg in case of insufficient efficacy) |
Recruiting |
Study Name: A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis Condition: Congenital Ichthyosis Date: 2016-08-03 Interventions:
|
Recruiting |
Study Name: A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis Condition: Ichthyosis Date: 2015-11-16 Interventions: Other: Observation |
Recruiting |
Study Name: Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous Condition: Lamellar Ichthyosis Date: 2010-10-12 Interventions: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side After |
Enrolling by invitation |
Study Name: Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris Condition: Ichthyosis Vulgaris Date: 2016-11-08 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis Condition: Ichthyosis, Lamellar Date: 2006-01-20 Interventions: Drug: Liarozole |